Bare Lymphocyte Syndrome Type 2 Complementation Group C is a rare genetic disorder that affects the immune system. This condition is caused by mutations in the RFX5 gene, which plays a critical role in the development and function of the immune system. Individuals with this syndrome have a significantly increased susceptibility to infections due to the impaired function of their immune system. DNA Labs UAE offers a comprehensive genetic test for this condition, aiming to provide essential information for the diagnosis and management of affected individuals. The cost of the RFX5 Gene Bare Lymphocyte Syndrome Type 2 Complementation Group C Genetic Test is 4400 AED. For more information, please visit our website at DNA Labs UAE.
Symptoms of RFX5 Gene Bare Lymphocyte Syndrome Type 2 Complementation Group C
The symptoms of Bare Lymphocyte Syndrome Type 2 Complementation Group C can vary significantly among affected individuals, but they generally revolve around the compromised immune system. The most common symptoms include:
- Recurrent respiratory infections, such as pneumonia and bronchitis
- Gastrointestinal infections, which can lead to chronic diarrhea and malabsorption
- Increased vulnerability to viral, bacterial, fungal, and parasitic infections
- Failure to thrive in infancy and early childhood
- Autoimmune disorders, where the immune system attacks the body’s own cells and tissues
Due to the wide range of potential infections and complications, early diagnosis and management are crucial for individuals with this syndrome. The genetic test offered by DNA Labs UAE provides valuable insights into the specific mutation affecting the RFX5 gene, allowing for a tailored approach to treatment and management.
Understanding the Genetic Test
The RFX5 Gene Bare Lymphocyte Syndrome Type 2 Complementation Group C Genetic Test is a specialized diagnostic tool designed to identify mutations in the RFX5 gene. This test involves analyzing the patient’s DNA, obtained through a simple blood sample, to detect the presence of mutations that cause the syndrome. The results of this test can confirm a diagnosis and help guide treatment decisions.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the RFX5 gene. Despite the cost, the value of this test lies in its ability to provide crucial information for the management of the syndrome, potentially improving the quality of life for affected individuals.
For more information about the RFX5 Gene Bare Lymphocyte Syndrome Type 2 Complementation Group C Genetic Test and to schedule an appointment, please visit DNA Labs UAE.
Early diagnosis and intervention are key to managing Bare Lymphocyte Syndrome Type 2 Complementation Group C effectively. With the help of DNA Labs UAE, individuals and families affected by this rare genetic disorder can access the support and resources they need for a better understanding and management of the condition.
